Ditchcarbon
  • Contact
  1. Organizations
  2. DURECT Corporation
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 2 months ago

DURECT Corporation Sustainability Profile

Company website

DURECT Corporation, a leading biopharmaceutical company based in the United States, focuses on developing innovative therapeutics for chronic diseases and pain management. Founded in 1998, DURECT has made significant strides in the industry, particularly with its proprietary drug delivery technologies and formulations. Headquartered in Cupertino, California, the company operates primarily in the biopharmaceutical sector, specialising in long-acting injectable products and novel drug delivery systems. DURECT's core offerings, such as its DUR-928 and the SABER® technology platform, stand out for their potential to enhance patient outcomes through improved efficacy and reduced side effects. With a strong market position, DURECT has garnered attention for its commitment to advancing healthcare solutions, making it a notable player in the biopharmaceutical landscape.

DitchCarbon Score

How does DURECT Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

DURECT Corporation's score of 23 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.

27%

Let us know if this data was useful to you

DURECT Corporation's reported carbon emissions

DURECT Corporation, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that DURECT Corporation may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the industry increasingly prioritises sustainability, DURECT Corporation's future climate commitments will be crucial for aligning with broader environmental goals.

How Carbon Intensive is DURECT Corporation's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. DURECT Corporation's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is DURECT Corporation's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for DURECT Corporation is in US, which has a low grid carbon intensity relative to other regions.

DURECT Corporation's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

DURECT Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare DURECT Corporation's Emissions with Industry Peers

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated 16 days ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 18 days ago

Zevra Therapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 18 days ago

Eli Lilly and Company

GB
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Vertex Pharmaceuticals

US
•
Pharmaceutical Preparation Manufacturing
Updated 18 days ago

Veloxis Pharmaceuticals A/S

DK
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251120.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy